Y-27632 (dihydrochloride)

Y-27632 dihydrochloride is an orally active and ATP-competitive ROCK (Rho-kinase) inhibitor (ROCK-I Ki=220 nM; ROCK-II Ki=300 nM). Y-27632 dihydrochloride shows antiepileptic effects[1][2][3][4].

[1]Tada S, et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol. 2001 Apr;34(4):529-36.|[2]Inan S, et al. Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice. Br J Pharmacol. 2008 Sep;155(1):44-51.|[3]Xue ZW, et al. Rho-associated coiled kinase inhibitor Y-27632 promotes neuronal-like differentiation of adult human adipose tissue-derived stem cells. Chin Med J (Engl). 2012 Sep;125(18):3332-5.|[4]Ishizaki T, et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol. 2000 May;57(5):976-83.Am J Physiol Cell Physiol. 2023 May 1.|Biochem Biophys Res Commun. 2021 Mar 18;552:142-149.|Biomaterials. 2021, 120684.|Biomolecules. 2023, 13(1), 69.|bioRxiv. 2023 Dec 22.|bioRxiv. 2023 Feb 16.|bioRxiv. 2024 Dec 11:2024.12.02.626470.|bioRxiv. 2024 Dec 5:2024.12.04.626665.|bioRxiv. 2024 Feb 1.|bioRxiv. 2024 Feb 27.|bioRxiv. 2024 Jan 5.|bioRxiv. 2024 November 18.|bioRxiv. 2024 October 27.|bioRxiv. 2024 September 14.|bioRxiv. April 21, 2022.|Breast Cancer Res. 2021 Aug 3;23(1):82.|Cancers (Basel). 2022 May 17;14(10):2463.|Cancers (Basel). 2023, 15(3), 931.|cell analysis. 2020 Aug.|Cell Mol Gastroenterol Hepatol. 2022 Nov 24;S2352-345X(22)00238-7.|Cell Rep. 2024 Jan 9;43(1):113668.|Cell Rep. 2024 Mar 1;43(3):113892.|Cell Rep. 2024 May 10;43(5):114206.|Cell Stem Cell. 2020 Jul 2;27(1):125-136.e7. |Cell Stem Cell. 2020 Jun 4;26(6):845-861.e12. |Cell Stem Cell. 2022 Jul 7;29(7):1102-1118.e8.|Cell Stem Cell. 2022 May 5;29(5):776-794.e13.|Cell Stem Cell. 2022 Oct 6;29(10):1475-1490.e6.|Cell Stem Cell. 2024 Jan 4;31(1):52-70.e8.|Cell. 2024 Nov 14;187(23):6566-6583.e22.|Curr Protoc Cell Biol. 2018 Dec;81(1):e62.|Curr Protoc. 2023 Oct;3(10):e915.|Environ Pollut. 2024 Mar 8:123743.|Environ Sci Technol. 2024 Apr 30.|Food Chem Toxicol. 2020 Jan;135:111015.|Heidelberg University. 2024.|Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):1. |iScience. 2022 Dec 26;26(1):105898.|iScience. 2023 May 29;26(7):107001.|iScience. 2024 Feb 5;27(3):109111.|iScience. 2024 Jul 8;27(8):110470.|J Adv Res. 2023 Oct 6:S2090-1232(23)00299-0.|J Adv Res. 2024 May 8:S2090-1232(24)00184-X.|J Allergy Clin Immunol. 2023 Dec 8:S0091-6749(23)02411-9.|J Biol Chem. 2022 Aug 12;102374.|J Biol Chem. 2024 Feb 1:105714.|J Environ Sci. 2023 Feb 23.|J Exp Clin Cancer Res. 2018 Jun 28;37(1):128. |J Hazard Mater. 2020 Jul 5;393:122440.|J Hazard Mater. 2021 Apr 5;407:124387.|J Hazard Mater. 2021 Jan 5;401:123341.|JCI Insight. 2023 Nov 8;8(21):e167874.|Life Sci. 2023 Jan 18;316:121404.|Microvasc Res. 2023 Sep 28:151:104611.|Nat Commun. 2023 Nov 27;14(1):7783.|Nat Protoc. 2021 Jan;16(1):352-382.|Nat Protoc. 2023 Feb 15.|Nature. 2022 Jan;601(7894):600-605.|Nature. 2022 Nov;611(7936):603-613.|Nutrients. 2023 Feb 9;15(4):887.|Patent. US20180263995A1.|Patent. US20220062272A1.|PLoS One. 2024 Feb 7;19(2):e0295030.|Research Square Preprint. 2020 Aug 20;rs.3.rs-62758.|Sci Adv. 2021 Sep 17;7(38):eabb5933.|Sci Total Environ. 2023 Dec 30:913:169702.|Science. 2020 Dec 4;370(6521):eaay2002.|STAR Protoc. 16 December 2022, 101786.|STAR Protoc. 2022 Sep 26;3(4):101720.|STAR Protoc. 2023 Jul 9;4(3):102431.|STAR Protoc. 2023 Nov 16;4(4):102683.|Stem Cell Res. 2024 Sep 14:81:103562.|Stem Cell Res. October 2021, 102544.|ACS Appl Mater Interfaces. 2022 May 11.|Acs Biomater Sci Eng. 2022 Mar 1.|Acs Biomater Sci Eng. 2023 Jan 20.|Acta Neuropathol Commun. 2024 Sep 14;12(1):150.|Acta Pharm Sin B. 2023 May 16.|Adv Healthc Mater. 2021 Feb 15;e2002103.|Adv Mater Interfaces. 2024 Sep 03.|Adv Sci (Weinh). 2020 Jun 17;7(15):1903583.|Adv Sci (Weinh). 2023 Nov 29:e2303088.|Adv Sci (Weinh). 2024 May 20:e2307216.|Adv Ther. 2024 April 30.|Adv Ther. 2024 Jul 18.|Anal Chem. 2017 Oct 17;89(20):10841-10849.|Ann Surg Oncol. 2024 Jan 4.|Arch Oral Biol. 2024 Oct 21:169:106115.|Bioact Mater. 14 August 2022.|Bioact Mater. 2021 Jun 1.|Bioact Mater. 2023 Aug.|Bioact Mater. 2024 Jun 14:40:244-260.|Biochem Biophys Rep. September 2022, 101299.|Biochem Biophys Res Commun. 2019 Aug 20;516(2):571-577.|Biochem Biophys Res Commun. 2019 Oct 29;519(1):134-140.|Biochem Biophys Res Commun. 2023|Bioengineered. 2022 Apr;13(4):8747-8758.|Bioengineering (Basel). 2020 Dec 18;7(4):164.|Biology (Basel). 2023, 12(6), 888.|Biomater Adv. 2023 Dec 26, 213751.|Biomaterials. 2020 May;240:119849.|Biomaterials. 2020 Nov;258:120284.|Biomaterials. 2024 Jan 1:305:122462.|Biomed Pharmacother. September 2022, 113465.|Biomed Res Int. 2021 May 15.|Biomedicines. 2024 Nov 27.|bioRxiv. 2020 Aug.|bioRxiv. 2020 Mar.|bioRxiv. 2023 Dec 6.|bioRxiv. 2023 Feb 24.|bioRxiv. 2023 Jul 1.|bioRxiv. 2023 Jun 22.|bioRxiv. 2023 Jun 28.|bioRxiv. 2023 Mar 1.|bioRxiv. 2024 Aug 12:2024.08.12.607571.|bioRxiv. 2024 Feb 18.|bioRxiv. 2024 Nov 15:2024.11.13.623500.|bioRxiv. 2024 November 15.|bioRxiv. 2024 November 26.|bioRxiv. 2024 September 07.|bioRxiv. January 16, 2022.|Biosci Biotechnol Biochem. 2021 Jul 23;zbab136.|BMC Cancer. 2023 Jun 22;23(1):577.|BMC Pulm Med. 2023 Dec 13;23(1):505.|BMC Urol. 2021 Jan 6;21(1):5.|Bone Res. 2022 Jan 3;10(1):1.|Brain Res. 15 December 2021, 147684.|Can Respir J. 10 Oct 2022.|Cancer Cell Int. 2024 Jul 25;24(1):263.|Cancer Cell. 2023 Jun 12;41(6):1103-1117.e12.|Cancer Cell. 2024 Jun 10;42(6):1086-1105.e13.|Cancer Lett. 2019 Apr 28;448:117-127.|Cancer Med. 2024 Nov;13(21):e70397.|Cancer Res. 2022 Dec 8;CAN-22-2370.|Cancers (Basel). 2021, 13(13), 3282.|Cell Biochem Biophys. 2023 Oct 6.|Cell Biosci. 2024 May 22;14(1):65.|Cell Death Dis. 2022 Aug 24;13(8):730.|Cell Death Dis. 2023 Apr 20;14(4):280.|Cell Death Dis. 2024 Aug 3;15(8):559.|Cell Death Discov. 2023 Jan 25;9(1):32.|Cell Discov. 2021 Apr 19;7(1):25.|Cell Discov. 2022 Apr 19;8(1):35.|Cell Prolif. 2022 Aug 3;e13320.|Cell Prolif. 2022 Mar 11;e13209.|Cell Prolif. 2024 Jan 12:e13599.|Cell Regen. 2020 Sep 3;9(1):15.|Cell Rep Med. 2023 Jan 10;100911.|Cell Rep Methods. 2024 Aug 27:100843.|Cell Rep Methods. 2024 May 8:100777.|Cell Rep. 2023 May 2;42(5):112445.|Cell Rep. 2023 Oct 5;42(10):113213.|Cell Rep. 2019 Jan 8;26(2):407-414.e5.|Cell Res. 2023 Jul 17.|Cell Signal. 2024 May 8:111223.|Cell Stem Cell. 2020 Oct 1;27(4):646-662.e7. |Cell Stem Cell. 2022 Sep 1;29(9):1346-1365.e10.|Cell Stem Cell. 2022 Sep 1;29(9):1366-1381.e9.|Cell. 2024 Jul 25;187(15):3936-3952.e19.|Cells. 2023 Dec 30, 13(1), 81.|Cells. 2024 Aug 31.|Cells. 2024 Oct 14;13(20):1697.|Chem Biol Interact. 17 August 2021, 109625.|Chem Eng J. 1 January 2023, 138737.|Chem Eng J. 2024 Apr 1, 485, 149884.|Circ Res. 2020 Oct 9;127(9):1182-1194.|Clin Mol Hepatol. 2023 Feb 20.|Compos Part B-Eng. 2023 Apr 6, 110711.|Connect Tissue Res. 2022 Jan 12;1-10.|Curr Med Sci. 2024 Jun 27.|Device. 2024 June 12|EBioMedicine. 2024 Oct 8:109:105390.|EJNMMI Res. 2024 Sep 27;14(1):86.|EMBO Mol Med. 2022 Dec 13;e16373.|Environ Pollut. 2020 Jun;261:114153.|Environ Toxicol Pharmacol. 2023 Oct 20:104301.|Eur J Cell Biol. 2024 May 28;103(2):151427.|Eur J Immunol. 2022 Aug;52(8):1308-1320.|Exp Mol Med. 2021 Sep 21.|Exp Mol Med. 2023 Jun 19.|Exp Ther Med. 2021 Feb 3.|F1000Research. 03 Aug 2022.|FASEB J. 03 October 2022.|FEBS J. 2024 Dec 17.|Food Chem Toxicol. 2024 Oct 8:115039.|Front Cell Dev Biol. 2021 Jun 24;9:670825.|Front Med. 2021 Sep 23;8:746298.|Front Physiol. 2020 Jun 30;11:669.|Gut Microbes. 2022, 14(1): 2139978.|Harvard Medical School LINCS LIBRARY|Hum Mol Genet. 2022 Aug 10;ddac190.|Immunity. 2022 Mar 15;S1074-7613(22)00124-8.|Int J Biol Sci. 2022 Aug 29;18(14):5459-5474.|Int J Chron Obstruct Pulmon Dis. 2024 Jul 8:19:1591-1601.|Int J Mol Med. 2024 Nov;54(5):99.|Int J Mol Sci. 2022, 23(23), 14637|Int J Mol Sci. 2023 Oct 31, 24(21), 15804.|Int J Mol Sci. 2024 Apr 9, 25(8), 4138.|Int J Stem Cells. 2023 May 30;16(2):156-167.|Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):19.|iScience. 19 October 2021, 103303.|iScience. 2023 Aug 26.|J Biol Chem. 2023 Oct 19:105361.|J Biol Eng. 2024 Jan 16;18(1):7.|J Biosci Bioeng. 2020 Dec 23;S1389-1723(20)30432-1.|J Bone Oncol. October 2021, 100391.|J Cancer Res Clin Oncol. 2024 Sep 19;150(9):424.|J Cell Mol Med. 2020 Jul;24(14):8179-8193.|J Clin Invest. 2022 Jan 25;e154993.|J Clin Med. 2019 Oct 21;8(10):1751.|J Immunother Cancer. 2024 Apr 19;12(4):e008628.|J Med Chem. 2019 Jul 11;62(13):6083-6101.|J Neuroinflammation. 2024 Apr 10;21(1):88.|J Neurosci. 2021 Jan 20;41(3):392-407.|J Transl Med. 2023 Oct 10;21(1):711.|J Virol. 2021 Feb 24;95(10):e02436-20.|J Virol. 2023 Apr 27;e0177022.|JCI Insight. 2024 Apr 23:e171916.|Life Sci. 2020 Apr 1;246:117419.|Life. 2021, 11(8), 789.|Mat Sci Eng C-Mater. 2021, 111939.|Med Sci Monit. 2018 May 27;24:3514-3523. |Methods Mol Biol. 2022 Dec 15.|Methods Mol Biol. 2023;2683:53-68.|Microsyst Nanoeng. 2024 Jul 15:10:97.|Mol Cancer. 2024 Jan 10;23(1):12.|Mol Cancer. 2024 Jun 8;23(1):125.|Mol Cell. 2021 Jul 1;81(13):2736-2751.e8.|Mol Med. 2023 Oct 20;29(1):139.|Mol Neurobiol. 2024 Mar 20.|Nat Cell Biol. 2022 Jun;24(6):858-871.|Nat Commun. 2022 Apr 19;13(1):2028.|Nat Commun. 2022 Jun 1;13(1):3060.|Nat Commun. 2022 Sep 6;13(1):5237.|Nat Commun. 2023 Apr 6;14(1):1912.|Nat Commun. 2023 Aug 8;14(1):4779.|Nat Commun. 2024 Aug 5;15(1):6626.|Nat Commun. 2024 Feb 19;15(1):1493.|Nat Commun. 2024 Feb 7;15(1):1150.|Nat Commun. 2024 Mar 11;15(1):2192.|Nat Commun. 2024 May 30;15(1):4590.|Nat Genet. 2024 Feb;56(2):294-305.|Neurotherapeutics. 2021 Jan 21.|NPJ Regen Med. 2022 Jun 16;7(1):31.|Npj Viruses. 2024 Sep 02.|Nutr Metab. 2020 Oct 26;17:91.|Oncogene. 2023 Aug 31.|Oncol Rep. 2020 Sep;44(3):1266-1274.|Oncotarget. 2017 Jul 31;8(47):82506-82530.|Patent. US20210284970A1.|Patent. US20220177852A1.|Patent. US20220267735A1.|Patent. US20240018470A1.|Patent. US20240325538A1.|Patent. US20240344020A1.|Patent. US20240344035A1.|Pharmacol Res. 2022 Dec 16;187:106615.|Phytother Res. 2024 Feb 15.|Protein Cell. 2021 Feb;12(2):107-127.|Reprod Toxicol. 2023 Dec 12:123:108522.|Research (Wash D C). 2023 Oct 24.|Research Square Preprint|Research Square Preprint. 2021 Jan.|Research Square Preprint. 2021 May.|Research Square Preprint. 2021 Oct.|Research Square Preprint. 2022 Jan.|Research Square Preprint. 2022 Jun.|Research Square Preprint. 2023 May 30.|Respir Res. 2022 Mar 25;23(1):70.|Sci Adv. 2023 Dec 22;9(51):eadi5683.|Sci Adv. 2023 Oct 27;9(43):eadg6686.|Sci Rep. 2017 Dec 19;7(1):17770.|Sci Rep. 2021 Dec 7;11(1):23564.|Sci Rep. 2019 Dec 17;9(1):19301. |Sci Total Environ. 2020 Jul 10;725:138433.|Sci Total Environ. 2022 May 18;838(Pt 2):155811.|Small Methods. 2024 Oct 17:e2401144.|Small. 2021 Jun 8;e2100546.|Small. 2021 Nov 2;e2104773.|SSRN. 2023 Feb 6.|SSRN. 2024 Jan 22.|STAR Protoc. 2021 Nov 5;2(4):100881.|STAR Protoc. 2023 Feb 3;4(1):102092.|Stem Cell Res Ther. 2024 Dec 3;15(1):463.|Stem Cell Res Ther. 2024 Oct 8;15(1):350.|Stem Cell Res Ther. 2019 May 31;10(1):155.|Stem Cell Res. 2021, 102157.|Stem Cell Res. 2021, 102217.|Stem Cell Res. 2022 Sep 15;64:102916.|Stem Cell Res. 2024 Feb 3:76:103327.|Stem Cell Res. 2024 Mar 24, 103399.|Theranostics. 2022 Mar 21;12(6):2908-2927.|Theranostics. 2022 Mar 28;12(7):3131-3149.|Theranostics. 2022; 12(17): 7250-7266|Theranostics. 2023 May 27;13(10):3290-3309.|Toxicology. 2020 Oct;443:152573.|Transl Lung Cancer Res. 2024 Oct 31;13(10):2698-2712.|Tumori. 2024 Oct 27:3008916241291301.|Vaccines. 2023 May 17, 11(5), 993.|Virology. 2023 May 3;583:45-51.|Virology. 2024 Dec.|Biomedicines. 2022 Apr 18;10(4):928.